Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

7.24
-0.1400-1.90%
Post-market: 7.240.00000.00%16:10 EDT
Volume:73.84K
Turnover:533.09K
Market Cap:36.13M
PE:-0.48
High:7.42
Open:7.27
Low:7.03
Close:7.38
52wk High:70.75
52wk Low:5.21
Shares:4.99M
Float Shares:3.75M
Volume Ratio:0.52
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.0059
EPS(LYR):-14.1162
ROE:-505.14%
ROA:-34.11%
PB:-0.68
PE(LYR):-0.51

Loading ...

Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 25, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Major Issues Report

8-K - Current report
Dec 22, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Major Issues Report

8-K - Current report
Oct 06, 2022

Major Issues Report

8-K - Current report
Aug 16, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Major Issues Report

8-K - Current report